Category Archives: News

Rightsline announces $500 million strategic growth investment from Hg to accelerate AI innovation and global expansion

No Comments
HG Capital

Los Angeles, CA – May 27, 2026: Rightsline, a leading provider of rights and royalties management software for IP-intensive industries, today announced a $500 million strategic growth investment from Hg, a leading investor in transatlantic technology businesses.

Klass Capital, Rightsline’s majority owner since 2020, Salem Partners, and the broader management team will invest meaningfully alongside Hg, reflecting their continued confidence in the business.

The global proliferation of streaming platforms, cross-border content licensing, and IP-intensive business models has created a growing operational challenge for rights holders, who need to track who owns what, where, and ensure the right parties get paid. Rightsline provides the software that major studios, publishers, consumer brands, and life sciences firms use to manage that complexity at scale.

Originally established as a leader in media and entertainment rights management, Rightsline now operates across eight IP-intensive verticals and serves more than 300 of the largest organisations worldwide, across media and entertainment, publishing, consumer products, life sciences, technology, gaming, music and franchising. The company offers a truly unified rights and royalties platform, with a single system spanning rights management, royalty calculation, financials, and accounting, delivering audit-grade outputs. The platform processes more than $40 billion of royalties annually and manages over 150 million IP assets across 28 countries.

 

2025 was a year of record growth for Rightsline across bookings, revenue and retention, reflecting the mission-critical role the platform plays in its customers’ day-to-day operations. This momentum continued into 2026 with another record quarter in Q1.

The company has already launched a suite of AI-powered products for its customers, including an AI contract ingestion assistant that automates extraction of key terms from complex legal agreements, and a natural-language rights and availabilities assistant that enables users to interrogate their rights libraries in plain English.

Hg’s investment will accelerate Rightsline’s product and AI roadmap and support the company’s international expansion, drawing on Hg’s transatlantic network and its team of more than 100 AI specialists. This includes Hg Catalyst, its dedicated AI product incubator, which has supported the launch of more than 30 AI products across its portfolio to date.

Patrick Arkeveld, CEO of Rightsline, said: “The IP landscape has become increasingly complex, with more platforms, territories, and contractual complexity than ever. That creates a clear opportunity for us to innovate on behalf of our customers and make their lives meaningfully easier, but more crucially to drive better business outcomes. Farouk and the Hg team are the ideal partner to help us deliver on that ambition, combining deep AI and operational expertise to accelerate our product roadmap and a transatlantic network to support our expansion into new geographies and verticals. We’re also grateful for the continued support of Daniel and Klass Capital, whose reinvestment reflects the shared conviction we all have in what lies ahead.”

Farouk Hussein, Partner at Hg, said: “Patrick, Daniel, and the Rightsline team have built something genuinely exceptional. Rightsline provides a truly unified rights and royalties platform, bolstered by proprietary calculation engines, data, and algorithms, enriched with decades of domain experience. The company boasts an impressive roster of blue-chip customers and a consistent track record of sustained growth and retention that speaks to how deeply embedded the product is in its customers’ legal, sales, finance and operations workflows. Rightsline is incredibly well-positioned to expands its presence across its core verticals with this growth investment, and we’re excited to work hand-in-hand with management and our Hg Catalyst team to build the next generation of agentic AI products for IP lifecycle management.”

Daniel Klass, Founder of Klass Capital, said: “Patrick and the team have built Rightsline into a clear global leader in rights and royalties software. When we set out to find our next partner, we wanted a firm that shares our growth ambitions and has the operational depth – particularly in AI and international scaling – to help take the company to the next level. Hg was the clear choice, and our decision to reinvest meaningfully alongside them reflects our strong conviction that the best chapter for Rightsline is still ahead.”

Donna Laing, Vice President, Royalty Accounting & Rights Data Management, Scholastic, said: “In publishing, royalties vary by channel, format, territory and more, and simply knowing what we have the right to sell in each market can be incredibly complex. Keeping track of all that, and making sure the right people get paid accurately, is a real operational challenge. Rightsline handles that complexity for us and, as the publishing world continues to grow more complex, we’re excited to see Hg’s investment accelerate what’s already an industry-leading platform.”

As part of the investment, Farouk Hussein and Annie Wei from Hg will join the Rightsline board alongside Daniel Klass and Patrick Arkeveld. Ron Kasner will join as independent Chair given his multi-decade experience in scaling technology companies.

Categories: News

Tags:

Littlejohn & Co. Closes Continuation Vehicle Anchored by Valcourt Group

Carlyle

Transaction led by Carlyle AlpInvest provides liquidity to existing investors while enabling Littlejohn to continue supporting Valcourt’s next phase of growth 

GREENWICH, Conn., May 27, 2026 – Littlejohn & Co., LLC (“Littlejohn”), a private investment firm, today announced the successful closing of a continuation vehicle anchored by the Valcourt Group (“Valcourt” or the “Company”), a leading provider of building envelope maintenance and restoration services for mid- and high-rise properties. The transaction provides optional liquidity to existing fund investors while enabling Littlejohn to continue its partnership with Valcourt during the Company’s next phase of growth. Carlyle AlpInvest served as lead investor in the transaction, with further participation from a group of blue-chip institutional investors. Financial terms were not disclosed.

Since Littlejohn’s initial investment in 2021, Valcourt has grown into a scaled, national platform with a differentiated position in building maintenance services. The Company has expanded its geographic footprint, broadened its service offering, and completed more than 20 acquisitions. Today, Valcourt serves a highly diversified base of more than 16,000 properties across the United States. The Company’s service offerings include waterproofing, restoration, roofing, window cleaning and other building envelope maintenance services, providing integrated solutions to customers.

The transaction represents a significant realization for Littlejohn. As part of the transaction, Littlejohn is making a new investment alongside CV investors, acquiring certain minority shareholder interests in Valcourt and further aligning ownership and positioning the business for continued growth.

Brian Michaud, Managing Director at Littlejohn, commented, “Since partnering with Valcourt in 2021, the Company has solidified its reputation as a leading exterior building maintenance platform dedicated to safety, service quality, and disciplined execution. Our successful partnership with Valcourt reflects our commitment to collaborating closely with founders and management teams to build differentiated platforms with scale and national presence.”

Will McDavid, Managing Director at Littlejohn, added, “We are thrilled to extend our partnership with the Valcourt team alongside Carlyle AlpInvest with fresh capital to support the Company’s organic and inorganic growth strategy. Our decision to reinvest speaks to our conviction in Valcourt’s long-term opportunity and the strength of the management team.”

Eric Crabb, CEO of Valcourt, said, “Over the past several years, Valcourt has grown from a regional operator into a national platform — executing more than 20 acquisitions, expanding our service capabilities, and building a leadership team to drive continued growth. We’re proud of what we have accomplished alongside Littlejohn and look forward to the next phase with both Littlejohn and Carlyle AlpInvest as partners.”

Michael Hacker, Partner at Carlyle AlpInvest, said, “This transaction reflects an important milestone in Carlyle AlpInvest’s more than 20-year relationship with Littlejohn and our shared conviction in Valcourt’s platform and long-term growth opportunity. The bespoke solution provided potential liquidity for Littlejohn investors across multiple funds while positioning Valcourt for continued expansion. We look forward to extending our partnership with Littlejohn and supporting Valcourt in its next chapter.”

Campbell Lutyens’ secondary advisory team served as lead financial advisor, and Harris Williams’ business services investment banking team served as co-advisor to Littlejohn. Kirkland & Ellis LLP served as legal counsel to Littlejohn. Troutman Pepper served as legal counsel to Valcourt. Ropes & Gray LLP served as legal counsel to Carlyle AlpInvest.

About Littlejohn & Co.:

Littlejohn & Co. is a Greenwich, Connecticut-based investment firm focused on private equity and debt investments in growing middle-market industrial and services companies that can benefit from Littlejohn’s 30 years of operational and sector expertise. With approximately $9.0 billion in regulatory assets under management, the firm seeks to build sustainable success for its portfolio companies through a disciplined approach to engineering change. For more information about Littlejohn, visit www.littlejohnllc.com.

About Carlyle AlpInvest:

Carlyle AlpInvest is a leading global private equity investor with $107 billion of assets under management and more than 710 investors as of March 31, 2026. It has invested with around 390 private equity managers and committed over $118 billion across primary commitments to private equity funds, secondary transactions, portfolio financings, and co-investments. Carlyle AlpInvest employs around 300 people in New York, Amsterdam, Hong Kong, London, and Singapore.

 

Media Contacts:

Nathaniel Garnick/Grace Cartwright

Gasthalter & Co.

littlejohn@gasthalter.com

(212) 257-4170

Categories: News

Carlyle Announces Expansion of its Capabilities in the Aerospace, Defense & Government and Industrial Sectors Through a Dedicated Middle-Market Platform

Carlyle

Washington, D.C. — May 27, 2026 — Carlyle (NASDAQ: CG) today announced an expansion of its Aerospace, Defense & Government and Industrial teams through a dedicated middle-market platform focused on opportunities across the United States and Europe. These efforts enhance Carlyle’s existing capabilities and build on Carlyle’s decades-long history supporting national security, defense modernization, industrial resilience, and supply chain transformation.

Ian Fujiyama, who has been with Carlyle for 28 years and currently serves as Global Head of Aerospace, Defense & Government, will serve as Chairman. The effort will be led by Aaron Hurwitz, who leads Carlyle’s investments in Defense, and Wes Bieligk, a Partner on Carlyle’s Industrials team.

Carlyle also announced that General Bryan Fenton (Ret.), former Commander of U.S. Special Operations Command, will join the firm as an Operating Executive. General Fenton will support Carlyle’s capabilities across the Aerospace, Defense & Government and Industrial teams through strategic sourcing, evaluation of investment opportunities, and engagement with management teams and industry stakeholders across the defense ecosystem.

“Carlyle’s roots in Washington, D.C. and our decades of experience investing across the defense and industrial sectors have given us a differentiated perspective on this market,” said Ian Fujiyama, Chairman of the platform and Global Head of Aerospace, Defense & Government at Carlyle. “We see this initiative as a natural extension of our broader franchise and an opportunity to dedicate capital and expertise to the middle-market segment across the U.S. and Europe.”

“The geopolitical environment and sustained increases in defense spending are creating a multi-decade investment opportunity across defense and industrial infrastructure,” said Admiral James Stavridis, Vice Chairman of Carlyle and former Supreme Allied Commander at NATO. “Governments are prioritizing military modernization, force preparedness, and resilient industrial capacity at a scale that we believe will drive long-term demand for advanced technologies and strategic capabilities.”

“We believe the opportunity set across defense and industrial resilience is significant and growing,” said Aaron Hurwitz and Wes Bieligk jointly. “With dedicated, local investment teams across the U.S. and Europe, deep sector expertise, and Carlyle’s resources, we believe we are well positioned to build and scale businesses that are essential to the industrial base.”

General Bryan Fenton added: “The national security landscape is evolving rapidly, increasing the need for innovation, resilient supply chains, and operational readiness. Carlyle’s experience, network, and long-term commitment to these sectors position us to support businesses developing mission-critical capabilities.”

Carlyle has invested across the Aerospace, Defense, Government and Industrial sectors for more than 35 years, including investments such as Booz Allen Hamilton, StandardAero, Two Six Technologies, Loc Performance, Allison Transmission, and Axalta. The firm leverages its extensive operating executive network, government affairs expertise, and broader value creation capabilities to support portfolio company growth and operational transformation.

About Carlyle

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $475 billion of assets under management as of March 31, 2026, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,500 people in 28 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.

 

Media Contacts

U.S. 

Brittany Bensaull

+1 (212) 813-4839

brittany.bensaull@carlyle.com

Europe

Andrew Kenny

+44 7385 662334

andrew.kenny@carlyle.com

Categories: News

Tags:

Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart

Blackstone

Up to $1.3 billion in flexible, non-dilutive capital, including up to $800 million of synthetic royalty and access of up to $500 million in senior corporate debt

Combined with company’s current total cash of $1.3 billion, this transaction positions Apogee to achieve a self-sustainable financial profile through commercialization of zumilokibart without need for future equity financing

Apogee to host webcast with the APEX Phase 2 Part B results today at 8:00 a.m. Eastern Time

San Francisco and Boston, May 27, 2026 — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, today announced that it has entered into a strategic financing collaboration with funds managed by Blackstone Life Sciences (“Blackstone”) for up to $1.3 billion in flexible, non-dilutive total capital to support the continued development and potential commercialization of zumilokibart.

“Our partnership with Blackstone Life Sciences represents a major milestone in the advancement of zumilokibart as the next meaningful first line therapy for moderate-to-severe atopic dermatitis,” said Michael Henderson, M.D., Chief Executive Officer of Apogee Therapeutics. “This collaboration provides non-dilutive flexible funding at an attractive cost of capital for the late-stage development of zumilokibart and establishes a path to commercialization and profitability for Apogee. As supported by our Apex Part B data announced today, we believe zumilokibart has the potential to be a transformative therapy for patients with differentiated efficacy and dosing in atopic dermatitis and other large I&I indications.”

“We are excited to support Apogee’s advancement of zumilokibart through Phase 3 development and potential commercialization,” said Dr. Nicholas Galakatos, Global Head of Blackstone Life Sciences. “Our collaboration with Apogee is a great example of our strategy to provide leading biotechnology companies with non-dilutive financing at scale and the resources and flexibility to further scientific innovation and invest in the advancement of their pipelines.”

Added Kiran Reddy, M.D., Senior Managing Director, Blackstone Life Sciences, “This is the largest royalty financing for a pre-Phase 3 program to date. It reflects our conviction that zumilokibart has the potential to become a highly differentiated, multi-indication product that will have a major impact on patients’ quality of life.”

Transaction Overview
The collaboration agreement provides for up to $1.3 billion in flexible, non-dilutive total capital, including up to $800 million of synthetic royalty and up to $500 million of senior debt available at the mutual consent of Apogee and Blackstone.

Synthetic royalty: Blackstone will provide up to $800 million of synthetic royalty funding in exchange for low-to-mid single digit tiered royalties for a term of 15 years on worldwide annual sales of zumilokibart. The royalties decrease based on sales with no royalties on global annual sales in excess of $8 billion.

  • The first $400 million in preapproval funding is divided into 3 tranches, including $100 million at signing, $100 million upon completion of zumilokibart Phase 3 enrollment, and $200 million upon positive Phase 3 data. Upon FDA approval of zumilokibart, up to $400 million in additional funding is available, $150 million of which is at Apogee’s option
  • The funding agreement includes specific provisions on a change of control, with the option to buy back a significant portion of the royalty.
  • Senior debt: Up to $500 million of senior corporate debt is available at mutual consent of Apogee and Blackstone

Additional details regarding the funding agreement can be found in the Current Report on Form 8-K filed by the company today with the U.S. Securities and Exchange Commission.

Cash runway update
As a result of entering into this funding agreement with Blackstone, the company is removing its cash runway end date guidance.

Webcast Details
Apogee Therapeutics will hold a live webcast to discuss the Blackstone transaction and the results of the APEX Phase 2 Part B trial today at 8:00 a.m. ET. The live webcast can be accessed via this link or the Investors section on the company’s website at https://investors.apogeetherapeutics.com/news-events/events. A replay of the webcast will be available following the call.

Advisors
Goldman Sachs served as exclusive financial advisor and Latham & Watkins LLP as legal counsel to Apogee Therapeutics. Ropes & Gray LLP served as legal counsel to Blackstone Life Sciences.

About Apogee
Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, including for the treatment of AD, asthma, eosinophilic esophagitis (EoE), Chronic Obstructive Pulmonary Disease (COPD) and other I&I indications. Apogee’s antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart, the company’s most advanced program, is being initially developed for the treatment of AD, which is the largest and one of the least penetrated I&I markets, as well as asthma and EoE. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today’s standard of care. For more information, please visit https://apogeetherapeutics.com.

About Blackstone Life Sciences
Blackstone Life Sciences (BXLS) is a leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, BXLS helps bring to market promising new medicines and medical technologies that improve patients’ lives and currently has $17 billion in assets under management.

Forward Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, statements regarding Apogee’s expectations regarding: Apogee’s plans for its current and future product candidates, programs, and clinical trials, including the Phase 3 development and potential commercialization of zumilokibart and expansion of zumilokibart into additional indications; the potential clinical benefit, dosing regimen, safety and efficacy profiles and treatment outcomes of zumilokibart, including its potential to be a best-in-class therapy, be the next meaningful first line therapy for AD, overcome limitations of existing therapies, and be the new standard of care in AD; the potential for Apogee product candidates and programs to overcome limitations of existing therapies; the potential of zumilokibart to become a differentiated, multi-indication product; its planned business strategies; the financial resources available to Apogee, including the availability of capital from the synthetic royalty and potential debt arrangement and whether Apogee achieves the milestones associated with certain payments thereunder and whether Apogee elects to receive optional funding under the arrangement, if available; its expectations regarding the time period over which Apogee’s capital resources will be sufficient to fund its anticipated operations, including its self-sustainable financial profile through commercialization of zumilokibart without the need for future equity financing; its potential profitability; and estimates of market size. Words such as “may,” “might,” “will,” “objective,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “design,” “estimate,” “predict,” “potential,” “develop,” “plan” or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While Apogee believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to Apogee on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in Apogee’s filings with the U.S. Securities and Exchange Commission (the SEC)), many of which are beyond Apogee’s control and subject to change. Actual results could be materially different. Risks and uncertainties include: global macroeconomic conditions and related volatility, expectations regarding the initiation, progress, and expected results of Apogee’s preclinical studies, clinical trials and research and development programs; expectations regarding the timing, completion and outcome of Apogee’s clinical trials; the unpredictable relationship between preclinical study results and clinical study results; the applicability of clinical study results to actual outcomes; the timing or likelihood of regulatory filings and approvals; liquidity and capital resources; and other risks and uncertainties identified in Apogee’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 2, 2026, and subsequent disclosure documents Apogee may file with the SEC. Apogee claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. Apogee expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.

Apogee Investor Contact:
Noel Kurdi
VP, Investor Relations
Apogee Therapeutics, Inc.
Noel.Kurdi@apogeetherapeutics.com

Apogee Media Contact:
Dan Budwick
1AB Media
dan@1abmedia.com

Blackstone Life Sciences Media Contact:
David Vitek
(212) 583-5291
David.Vitek@Blackstone.com

Categories: News

Tags:

Bain Capital and 11North Partners Acquire Five Open-Air Retail Centers for $300 Million

BainCapital

Platform Reaches 18 Assets and Nearly $1 Billion of Capital Invested

BOSTON & NEW YORK – May [XX], 2026 – Bain Capital and 11North Partners (“11North”) today announced the acquisition of five open-air retail centers located across California, Virginia, Florida, and Texas for approximately $300 million. The private transactions were executed through an exclusive joint venture between Bain Capital Real Estate and 11North focused on investing in high-quality open-air retail centers throughout the United States and Canada and across the core plus and value add spectrum.

Collectively, the portfolio totals approximately 757,000 square feet and spans Carlsbad, CA (North County San Diego), Falls Church, VA (Fairfax County), Altamonte Springs, FL (Orlando), and Sugar Land, TX (Houston) – all dense and affluent submarkets benefiting from strong retail fundamentals.  The centers are anchored by Harris Teeter, Trader Joe’s, Walmart, Costco, and Equinox, with anchor sales per square foot in excess of $900.  The portfolio, with in-place occupancy exceeding 93%, features a dynamic mix of food, fitness, medical, service and other necessity tenants, with low tenant health ratios.

“Open-air, grocery-anchored retail continues to demonstrate some of the most compelling risk-adjusted fundamentals in the real estate landscape. We are acquiring high quality, irreplaceable assets in undersupplied markets at a basis that would be structurally difficult to replicate,” said Brian Harper, Founder and Managing Partner, 11North.  “The demographic quality across this portfolio, with nearly $132,000 average household income within three miles, is a direct reflection of where we choose to allocate capital. These assets were individually curated based on the team’s decades of investing across the country, coupled with a data driven foundation. With several billion of remaining dry powder, we will remain disciplined in how and where we invest.”

“These assets align squarely with our strategy of building a portfolio of institutional quality, open-air centers, anchored by best-in-class necessity and lifestyle tenants that serve as cornerstones of their communities. Each asset was underwritten using our proprietary data-driven framework, which allows us to evaluate markets, submarkets, and individual assets with a level of precision and conviction we believe is differentiated in this sector,” said Martha Kelley, a Managing Director at Bain Capital Real Estate. “Following our successful joint capital raise in December, our platform is well capitalized to continue scaling with discipline, and partnering shoulder-to-shoulder with 11North gives us the retail investment and operational expertise to create lasting value for our investors and the communities these centers serve.”

The acquisition of these five assets follows Bain Capital and 11North’s recent capital raise of $1.6 billion dedicated to investing in open-air retail through the co-owned, 11North platform.  Together with participation from Bain Capital Real Estate Fund III, the platform has access to more than $2 billion of investable equity.  Since launching their joint venture in April 2024, Bain Capital and 11North have curated a portfolio of 18 assets totaling over two million square feet across six transactions.  With nearly $1 billion of capital deployed to date, the partnership remains focused on expanding its portfolio in markets with strong demographic tailwinds and exceptional retail productivity.

###

About Bain Capital Real Estate
Bain Capital Real Estate pursues investments in often difficult-to-access sectors underpinned by enduring secular trends that drive long-term demand growth for real estate assets and services. The Bain Capital Real Estate team has invested and committed over $10.7 billion of equity across multiple sectors [as of December 31, 2025. Bain Capital Real Estate focuses on assets where the team applies its deep industry expertise to accelerate impact and drive operational improvements. Bain Capital Real Estate’s strategy aligns with the value-added investment approach that Bain Capital pioneered and leverages the firm’s global platform and significant experience across asset classes to further bolster its insights and sourcing capabilities. Bain Capital is one of the world’s leading private investment firms, with approximately $225 billion of assets under management. For more information, visit https://www.baincapitalrealestate.com.

About 11North Partners
11North Partners is a real estate investment firm focused on curating a portfolio of retail investments diversified across markets and product types. With a focus on the intersection of superior performance and bold vision, the 11North team is dedicated to redefining the traditional approach to retail real estate. The team’s combination of deep industry expertise, retailer and owner relationships, and blue-chip institutional partners provides unique insight into the ever-evolving retail landscape and unparalleled access to deal flow. 11North seeks to deliver attractive risk-adjusted returns through unlocking value across retail verticals including real estate ownership, debt and operating company investment. For more information, visit https://www.11northpartners.com.

Categories: News

Tags:

Ardian Clean Energy Evergreen Fund (ACEEF) enters the Uruguayan renewables market through acquisition of a 76MWp operating solar portfolio

Ardian

ACEEF acquires two operating solar PV plants with a combined capacity of 76MWp located in Uruguay
• The acquisition marks ACEEF’s entry into Uruguay and further expands Ardian’s renewable footprint in Latin America

Ardian, a global private investment firm, today announces that it has acquired two operating solar PV plants in Uruguay with a combined capacity of 76MWp.

The investment marks ACEEF’s first entry into the Uruguayan renewable energy market, further expanding Ardian’s footprint in Latin America. Uruguay benefits from strong renewable fundamentals, including a well-established regulatory framework and a high degree of revenue visibility, providing a supportive environment for long-term investment. Ardian intends to build its presence in the market over time through further investment opportunities.

The portfolio will be managed by AGR-AM, Ardian’s renewable energy platform in Latin America and Spain, which will oversee asset management and operational optimisation. The assets will also benefit from integration with OPTA, Ardian’s proprietary data analytics platform designed to optimise the management of renewable energy assets and support value creation across the portfolio.

Ardian already has a presence in Uruguay, through its investment in Akuo, which operates a portfolio of renewable assets in the country. More broadly, ACEEF has a long-standing presence in South America via solar PV assets in Chile, and hydropower and solar PV assets in Peru. This footprint supports Ardian’s ability to source, execute and manage investments locally.

The acquisition also strengthens the fund’s international renewable portfolio, providing further geographic diversification and supporting its strategy of building scalable positions in attractive markets.

“ACEEF is built around a selective and disciplined investment strategy focused on scalable platforms, diversified geographies and assets with strong contractual frameworks. Our entry into Uruguay adds high-quality operating capacity that supports stable yields, limits revenue volatility, and strengthens the fund’s diversified exposure to core renewable technologies.” Benjamin Kennedy, Managing Director Renewables, Ardian

“This transaction builds on AGR AM’s strong experience and operational track record across the region, enabling us to identify high quality opportunities and deliver value at scale. We look forward to building a strong and sustainable footprint in the market.” Angel Hernandez Del Teso, CEO AGR-AM

ACEEF is Infrastructure’s first open-ended clean energy fund, which was launched in early 2022 and whose fundraising reached €1.0bn at the closing in July 2023. The fund offers professional investors the opportunity to enhance their exposure to renewable assets and the energy transition. The fund commits to making investments with an environmental objective as described in Article 9 fund of the EU Sustainable Finance Disclosure Regulation (SFDR) and invests globally, with a focus on Europe.

ACEEF will continue to focus on core renewable technologies – namely solar, wind and hydro, as well as emerging technologies across biogas, biomass, storage and energy efficiency. ACEEF currently manages 1.5GW of operating capacity across 5 platforms.

Ardian has been a pioneer in the energy transition, having started investing in renewable assets in 2007. Across all Infrastructure Funds at Ardian, the team manages more than 10GW of clean energy capacity in Europe and the Americas.

ABOUT ARDIAN

In a world of constant evolution, Ardian stands out for its ability to anticipate, adapt, and turn challenges into opportunities. As a global, diversified private markets firm with 22 offices and more than 350 investment professionals worldwide, we provide investment and customized solutions that reflect new economic dynamics and help our clients remain resilient in a changing world.
We deliver multi-local expertise and long-term performance for our investors and partners as well as shared value for the broader society. Since Ardian’s inception in 1996, our pioneering approach to diversification and our ability to offer tailor-made solutions at scale have remained the heart of our strategy.
Through commitment, knowledge and technology, we bring lasting value to our companies and contribute positively to the whole industry.
Ardian currently manages or advises $200bn for more than 1,920 clients worldwide across Private Equity, Real Assets, and Credit.
Ardian. Mastering change for lasting value.

ardian.com

Media contacts

HEADLAND

ardian@headlandconsultancy.com

Categories: News

Tags:

DigitalBridge and ArcLight Announce Strategic Combination to Form a Leading Alternative Asset Manager at the Convergence of Power, AI, and Digital Infrastructure

No Comments
Arclight

ArcLight Will Continue to Operate as a Distinct Business Within DigitalBridge Group Following the Completion of SoftBank Group’s Pending Acquisition of DigitalBridge Group

original

BOCA RATON, Fla. & BOSTON–(BUSINESS WIRE)–DigitalBridge Group, Inc. (NYSE: DBRG) (“DigitalBridge”), a leading global alternative asset manager dedicated to digital infrastructure, today announced that it has entered into a definitive agreement to acquire ArcLight Capital Partners, LLC (“ArcLight”), one of North America’s leading specialist investors in power and electric infrastructure, for a total transaction value of up to $1.05 billion. The consideration includes a base purchase price of $650 million, plus up to an additional $400 million of contingent consideration. The combination forms a leading alternative asset manager at the convergence of power, AI, and digital infrastructure, bringing together two specialist platforms with combined assets representing more than $150 billion.

Since ArcLight’s founding in 2001, ArcLight has owned, controlled, or operated over 70 GW of generation assets and 48,000 miles of electric and gas transmission and storage infrastructure, representing more than $90 billion of enterprise value. The firm operates one of the largest private power generation portfolios and development pipelines in North America, supported by an integrated platform of strategic, technical, operational, and commercial specialists, including an 85-person power development organization with a pipeline exceeding 15 GW.

The transaction is conditioned upon completion of the previously announced acquisition of DigitalBridge by an affiliate of SoftBank Group Corp. (the “SoftBank Acquisition”) and will not alter or affect the terms of or consideration payable under the SoftBank Acquisition.

With SoftBank Group’s leadership across the global technology and AI landscape, the transaction will bring together two leading investment managers in the digital infrastructure and power infrastructure sectors – forming a platform with the scale, development capabilities, and relationships – to invest behind growing demand for compute, connectivity, and power. The combination is expected to enable new investment solutions that draw on the specialist expertise of both firms to mobilize capital for future power and digital infrastructure development across North American and global markets.

“Digital infrastructure is a specialist business, and ArcLight has operated with that same philosophy in power infrastructure for more than two decades, building deep expertise across power, renewables, batteries, transmission, and midstream infrastructure,” said Marc Ganzi, Chief Executive Officer of DigitalBridge. “The shared conviction that specialization creates durable advantages is foundational to this combination and expands what we can deliver for our limited partners and customers. AI is rewiring the global power equation, accelerating investment across generation, transmission, and behind-the-meter infrastructure. We believe the firms best positioned for this next phase of growth will be those that are able to underwrite both digital and energy infrastructure with equal depth and credibility. Together, DigitalBridge and ArcLight will help create a scaled infrastructure platform positioned for that convergence. We are privileged to welcome Daniel Revers, Angelo Acconcia, Jake Erhard, and the broader ArcLight team to DigitalBridge as we continue building differentiated infrastructure capabilities together.”

“I founded ArcLight in 2001, as one of the first dedicated power infrastructure investment platforms, and more than two decades later we are taking another significant step toward building a platform for the growing convergence of power, AI, and digital infrastructure,” said Mr. Revers, Founder of ArcLight. “As demand for compute, connectivity, and electrification continues to accelerate, we believe the next phase of infrastructure investing will increasingly require integrated expertise across both power and digital infrastructure. This combination builds on ArcLight’s strong foundation and creates new opportunities for our investors, customers, and partners, while preserving the independence, discipline, and long-term focus that has defined our business since inception. By combining ArcLight’s deep experience across power infrastructure with DigitalBridge’s global digital infrastructure platform and longstanding relationships across the hyperscale ecosystem, and SoftBank Group’s broader technology and AI leadership, we believe the combined platform will be well positioned to support the next generation of infrastructure development.”

“Meeting the power demands of AI infrastructure, reshoring, and electrification is a generational opportunity. Power has become the critical bottleneck for digital infrastructure buildout, and solving it takes expertise and dedicated people,” said Mr. Acconcia, Managing Partner of ArcLight. “We’ve built 25 years of technical knowledge, regulatory relationships, and operational depth in electrification infrastructure. Over the past five years alone, we have significantly expanded our team, resources, and capabilities to create an integrated platform to meet this need at scale. ArcLight looks forward to building on this momentum in partnership with DigitalBridge as we execute on an integrated approach to powering the digital economy.”

ArcLight will operate as a separately managed business as part of the DigitalBridge platform. ArcLight will maintain continuity in its investment processes consistent with its long-standing commitments to limited partners, including its focus on targeting attractive risk-adjusted returns and DPI, disciplined risk management, and partnership-based approach, which will remain intact.

Upon completion of the transaction, and as part of the ArcLight team’s long-term commitment to the continued growth of the platform, Mr. Revers will serve as Vice Chairman of DigitalBridge. Mr. Acconcia will serve as Managing Partner of ArcLight, continuing his day-to-day leadership of the firm. Mr. Erhard, currently a Partner at ArcLight, will become Senior Partner.

Transaction Details

The transaction is subject to customary closing conditions, including required regulatory approvals, requisite limited partner consents, and the completion of the SoftBank Acquisition. The merger agreement will be filed with the SEC.

Barclays is acting as financial advisor and sole committed financing provider to DigitalBridge. Simpson Thacher & Bartlett LLP is serving as legal counsel to DigitalBridge, along with Morgan, Lewis, & Bockius as regulatory counsel. Morgan Stanley & Co. LLC is serving as financial advisor, and Kirkland & Ellis LLP is serving as legal counsel to ArcLight. Sullivan & Cromwell LLP is serving as legal counsel to SoftBank Group, along with Morrison & Foerster LLP and Covington & Burlington LLP as regulatory counsel.

About DigitalBridge Group, Inc.

DigitalBridge (NYSE: DBRG) is a leading global alternative asset manager dedicated to investing in digital infrastructure. With a heritage of more than 30 years investing in and operating businesses across the digital ecosystem, including cell towers, data centers, fiber, small cells, and edge infrastructure, DigitalBridge manages infrastructure assets on behalf of its limited partners and shareholders. The firm is headquartered in Boca Raton, Florida, with offices across North America, Europe, the Middle East, and Asia. References to “DigitalBridge” herein refers to DigitalBridge Group, Inc. and/or its managed investment vehicles, as the context requires. For more information, visit www.digitalbridge.com.

About ArcLight Capital Partners

ArcLight is a leading infrastructure investor which has been investing in critical electrification infrastructure since its founding in 2001. ArcLight has owned, controlled or operated over 70 GW of assets and 48,000 miles of electric and gas transmission and storage infrastructure representing more than $90 billion of enterprise value. ArcLight has a long and proven history of value-added investing across its core investment sectors including power, hydro, solar, wind, battery storage, electric transmission, natural gas transmission, storage infrastructure and digital power to support the growing need for power, reliability, security, and sustainability. ArcLight’s team employs an operationally intensive investment approach that benefits from its dedicated in-house strategic, technical, operational, and commercial specialists, as well as the firm’s ~2,000-person asset management partner. References to “ArcLight” herein refers to ArcLight Capital Partners, LLC and/or its managed investment vehicles, as the context requires. For more information, please visit www.arclight.com.

Forward-Looking Statements

Some of the statements contained in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Exchange Act, and we intend such statements to be covered by the safe harbor provisions contained therein. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” or “potential” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions.

The forward-looking statements, including but not limited in respect of any targeted returns, contained in this press release reflect our current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause our actual results to differ significantly from those expressed in any forward-looking statement. The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: (i) uncertainties as to the timing of the ArcLight transaction and the SoftBank Group transaction; (ii) the risk that the ArcLight transaction and/or the SoftBank Group transaction may not be completed on the anticipated terms in a timely manner or at all; (iii) the failure to satisfy any of the conditions to the consummation of the ArcLight transaction and/or the SoftBank Group transaction; (iv) the possibility that any or all of the various conditions to the consummation of the ArcLight transaction and/or SoftBank Group transaction may not be satisfied, in a timely manner or at all, or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals); (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the ArcLight merger agreement and/or the SoftBank Group merger agreement, including in circumstances which would require DigitalBridge to pay a termination fee; (vi) the effect of the announcement or pendency of the ArcLight transaction and/or the SoftBank Group transaction on DigitalBridge’s ability to retain and hire key personnel, its ability to maintain relationships with its customers, suppliers and others with whom it does business, or its operating results and business generally; (vii) costs relating to the ArcLight transaction and the SoftBank Group transaction (including in respect of the financing of the ArcLight transaction) may be greater than expected; (viii) risks related to diverting management’s attention from DigitalBridge’s ongoing business operations; (ix) the risk that litigation in connection with the ArcLight transaction, the SoftBank Group transaction or the outcome of any other legal proceedings that may be instituted against DigitalBridge, ArcLight, SoftBank Group and/or others relating to the ArcLight transaction and/or the SoftBank Group transaction may result in significant costs of defense, indemnification and liability; (x) certain restrictions during the pendency of the SoftBank Group transaction that may impact DigitalBridge’s ability to pursue certain business opportunities or strategic transactions; (xi) risks that the benefits of the ArcLight transaction and/or the SoftBank Group transaction are not realized when and as expected; (xii) the risk that DigitalBridge’s, SoftBank Group’s and/or ArcLight’s businesses will be adversely impacted during the pendency of the acquisitions; (xiii) legislative, regulatory and economic developments; and (xiv) (A) the risk factors described in Part I, Item 1A of Risk Factors in DigitalBridge’s Annual Report on Form 10-K for the year ended December 31, 2025 and (B) the other risk factors identified from time to time in DigitalBridge’s and/or ArcLight’s other filings with the Securities and Exchange Commission (the “SEC”). Filings with the SEC are available on the SEC’s website at http://www.sec.gov and/or on DigitalBridge’s website. These forward-looking statements speak only as of the date of this press release. Neither DigitalBridge nor ArcLight undertakes any obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes, except as otherwise required by law.

While forward-looking statements reflect our good faith beliefs, assumptions and expectations, they are not guarantees of future performance. Furthermore, we disclaim any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, or new information, data or methods, future events or other changes. Moreover, because we operate in a very competitive and rapidly changing environment, new risk factors are likely to emerge from time to time. We caution investors not to place undue reliance on these forward-looking statements and urge you to carefully review the disclosures DigitalBridge makes concerning risks in Part I, Item 1A. “Risk Factors” and in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in DigitalBridge’s Annual Report on Form 10-K for the year ended December 31, 2025. Readers of this press release should also read our other periodic filings made with the SEC and other publicly filed documents for further discussion regarding such factors.

 

Contacts

Media Contacts:

DigitalBridge
Joele Frank, Wilkinson Brimmer Katcher
Erik Carlson / Alexander Wolfsohn
(212) 355-4449
dbrg-jf@joelefrank.com

Arclight Capital Partners
Stanton
Charlyn Lusk / Josh Greenwald
clusk@stantonprm.com / jgreenwald@stantonprm.com
(646) 502-3549 / (646) 504-7306

Categories: News

Tags:

Stonepeak-led Consortium to Acquire Estia Health

Stonepeak

 

SYDNEY – 27 May 2026 – Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, today announced it has entered into a definitive agreement to acquire a majority stake in Estia Health, one of Australia’s leading residential aged care operators, from Bain Capital. The transaction marks a second investment for Volarae Living, Stonepeak’s social infrastructure platform in Australia and New Zealand, following its February 2026 investment in Aura Holdings.

Headquartered in Sydney, Estia Health is the second largest residential aged care operator in Australia, operating more than 90 homes across New South Wales, Queensland, South Australia, and Victoria, and caring for approximately 9,000 residents. Since its founding in 2014, Estia Health has thoughtfully expanded its footprint while continuing to invest in its employees, residents, and their families as part of its commitment to person-centered care.

“Residential aged care is, and will continue to be, an essential service and important component of Australia’s overall healthcare system, especially against the backdrop of an aging population,” said Darren Keogh, Senior Managing Director at Stonepeak. “We are thrilled to support Estia Health, a high-quality provider, build on its positive momentum, and even better serve older Australians.”

“I welcome the commitment to continuity for our residents, families and teams, and to ongoing investment in the capability of our people and systems so we can continue delivering high-quality care,” said Sean Bilton, CEO of Estia Health. “We look forward to working with Stonepeak, whose complementary experience and long-term investment approach support our strategy and build on our strong foundations. It remains our privilege to care for older Australians and support residents and their families at an extremely important time in their lives — and that will not change with our ownership.”

Stonepeak’s consortium partner in the transaction is Axight Capital Limited (Axight). The minority stake in Estia Health represents Axight’s second investment in Australia, further deepening its focus in the Asia Pacific Region.

“Estia Health has established itself as one of Australia’s leading residential aged care operators, underpinned by a strong reputation for quality care, operational excellence, and a deep commitment to residents, families and employees. We are delighted to be partnering with Stonepeak, whose significant expertise and proven experience across aged care and retirement living will be highly valuable as we support Estia Health’s continued growth,” said Jerry He and Mujtaba Hussain, Co-Managing Partners at Axight.

The transaction is expected to close in late 2026, subject to customary regulatory approvals. Terms of the transaction were not disclosed.

About Stonepeak
Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately A$125 billion (US$88 billion) of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, with a focus on downside protection and strong risk-adjusted returns. Stonepeak, as sponsor of private equity and credit investment vehicles, provides capital, operational support, and committed partnership to grow investments in its target sectors, which include digital infrastructure, energy and energy transition, transport and logistics, and real estate. Stonepeak is headquartered in New York with offices in Houston, Washington, D.C., London, Hong Kong, Seoul, Singapore, Sydney, Tokyo, Abu Dhabi, and Riyadh. For more information, please visit www.stonepeak.com.

Media Contacts

For Stonepeak:
Kate Beers / Maya Brounstein
corporatecomms@stonepeak.com
+1 (646) 540-5225

Jack Gordon
jack.gordon@sodali.com
+61 478 060 362

 

Categories: News

Tags:

Oakley Capital invests in enterprise software platform XTEL

BainCapital

LONDON – May 26, 2026: Oakley Capital, a leading mid-market, pan-European private equity investor, is pleased to announce it is acquiring a majority stake in XTEL, a leading provider of revenue management and trade promotion software for consumer packaged goods companies, from existing shareholders Bain Capital and SilverTree Equity.

XTEL’s software platform enables consumer packaged goods companies, including food, beverage and household brands, to plan, manage and optimise the trade promotions they run with retailers. The platform analyses large amounts of sales, pricing, customer and financial data to help businesses manage and optimise promotions in order to improve
profitability and drive revenue growth.

The Company serves more than 400 global mega-brands, including Unilever, PepsiCo and Johnson & Johnson, and supports over €350 billion in annual trade spend.

XTEL operates in an $11 billion CPG software market underpinned by structural tailwinds, including sustained pressure on CPG margins, retailer consolidation, improved access to consumer data, and growing omni-channel complexity. At the same time, rapid adoption of AI and data-driven decision-making is accelerating demand for best-in-class platforms such as XTEL.

XTEL’s software brings together large amounts of complex sales and commercial data into one system that customers rely on as a core system of record. Combined with the Company’s deep industry expertise, this creates a highly embedded and mission-critical solution. AI is expected to further enhance the platform’s capabilities, enabling customers to make faster and better decisions using the data already managed within XTEL.

XTEL has consistently generated strong, profitable growth including ARR growth of c.40% CAGR over the last three years. Oakley Capital will leverage its extensive track record of supporting European software businesses to drive growth through international expansion and M&A. This investment will support XTEL in accelerating its presence in key growth markets such as Latin America and Asia-Pacific, while also expanding into adjacent geographies, brands and product categories, and further strengthening its AI tech stack, sales capabilities and go-to-market strategy.

XTEL will continue to be led by Rob Mullen, a highly experienced enterprise software CEO who has transitioned XTEL to a system-of-records SaaS platform, while successfully pursuing organic and M&A growth.

Oakley Capital co-Founder and Managing Partner Peter Dubens said: “XTEL’s software is trusted by the world’s leading consumer brands to power essential workflows, while its deep expertise in complex data underpins its role as a critical system of record. We believe the Company is well-positioned to harness AI to enhance its product offering and further strengthen its market position. We look forward to working with CEO Rob Mullen to support the next stage of XTEL’s growth.”

Bain Capital’s Giovanni Camera, Alberto De Antoni and Paolo Vismara said: “From the outset of our investment in Kantar, we identified XTEL as a high-potential software business with the ability to become a focused, independent leader in its market. Since then, we have supported the Company’s carve-out and invested behind its growth, and it has been exciting to see XTEL evolve into a leading high growth global software platform for revenue growth management in the CPG industry. We are proud of what Rob and the entire XTEL team have achieved, and confident the business is well placed to continue its growth journey with Oakley Capital.”

SilverTree Equity Partners John Messamore and Nicholas Theuerkauf, added: “We are proud to have backed XTEL through its separation from Kantar. In the past four years XTEL has tripled its ARR and has been transformed into the leading independent AI-enabled revenue growth management platform serving global CPG companies. It has been a pleasure working with Rob and the team and we are delighted to be remaining invested to support XTEL’s next phase of growth.”

XTEL CEO Rob Mullen said: “I’m very pleased to welcome Oakley Capital as our new investor after a successful partnership with Bain Capital and SilverTree Equity.  Their combined expertise in building European technology champions is highly relevant for XTEL as we look to accelerate our growth by expanding into new regions, products and industry verticals.”

Evercore served as exclusive financial advisor to XTEL, Bain Capital and SilverTree Equity.

ENDS

About Oakley Capital 
Founded over 20 years ago, Oakley Capital was established to be the partner of choice for exceptional founders and entrepreneurs. We invest in private, pan-European businesses with enterprise values ranging from €100 million to over €1 billion. Our team comprises more than 250 professionals across our offices in London, Munich, Milan, Madrid, and Luxembourg, providing genuine European reach combined with deep local expertise and cultural insight. Through our differentiated origination capabilities, we uncover attractive investment opportunities across four core sectors: Technology, Consumer, Education, and Business Services. We prioritise long-term, repeat partnerships with outstanding founders, many of whom choose to reinvest in our funds. To date, we have raised nine funds, including Fund VI, which closed at its €4.5 billion hard cap in 2025. Across the Group, Oakley manages in excess of c.€16 billion on behalf of our investors, generating consistently strong returns for all our stakeholders. www.oakleycapital.com

About Bain Capital
Founded in 1984, Bain Capital is one of the world’s leading private investment firms. We create lasting impact for our investors, teams, businesses, and the communities in which we live. As a private partnership, we lead with conviction and a collaborative culture that enables us to innovate, unlock opportunity, and deliver strong outcomes. Our global platform invests across Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. Across these focus areas, we bring deep sector expertise and broad capabilities. We have 24 offices on four continents, more than 1,850 employees, and approximately $225 billion in assets under management. To learn more, visit www.baincapital.com. Follow @BainCapital on LinkedIn and X.

About SilverTree Equity
SilverTree Equity is a private equity firm, with ~$1bn AUM, focused on control buyouts of middle market software and tech-enabled services companies run by an experienced team of investment and operating professionals with backgrounds at leading global private equity firms including Hg Capital, Marlin Equity Partners and Advent International. SilverTree has completed 30 transactions since late 2019. For more information, please visit www.silvertree-equity.com.

Categories: News

Tags:

Bain Capital to Exit Estia Health

BainCapital

SYDNEY – May 26, 2026 – Bain Capital, a leading global private investing firm, today announced it has entered into an agreement to sell Australian aged care provider Estia Health to alternative investment firm Stonepeak. Financial details were not disclosed.

Bain Capital acquired Estia Health in December 2023. The company is one of Australia’s leading residential aged care providers, operating homes across New South Wales, Queensland, Victoria, and South Australia. It is driven by its purpose to enrich and celebrate life together, delivered through the provision of high-quality residential aged care services to older Australians.

During Bain Capital’s investment period, Estia Health has grown from 73 homes with approximately 6,720 residents to 93 homes and approximately 9,250 residents. More than 14,000 people are now employed across the business.
The firm’s investment in Estia Health has been led by Australian-based Partners Mike Murphy, Charles Lawson, and Grace Mollard.

“Bain Capital is proud of the partnership we have built with Estia Health and its outstanding management team. We are deeply appreciative of the trust that families place in the company to care for their loved ones. We wish the entire team every success as they continue their important work,” Murphy said.

“During our ownership, we have supported Estia Health to deliver high quality of care and have invested heavily to grow its footprint and expand access to care. The significant increase in both the number of homes and residents served reflects our conviction in the company’s mission and our commitment to making a genuine difference in the lives of older Australians and their families,” Lawson added.

“We are proud to leave Estia Health an even stronger and more resilient business than when we first partnered together. The company is exceptionally well positioned to continue to play a leadership role in a critical sector. We have great confidence in the team and in Estia Health’s ability to continue delivering for residents, families, and the communities it serves,” Mollard concluded.

The transaction is expected to complete in late 2026, subject to standard regulatory approvals.

Barrenjoey and Gresham acted as financial advisors to Bain Capital. Allens acted as legal advisors.

ENDS

About Bain Capital

Founded in 1984, Bain Capital is one of the world’s leading private investment firms. We create lasting impact for our investors, teams, businesses, and the communities in which we live. As a private partnership, we lead with conviction and a collaborative culture that enables us to innovate, unlock opportunity, and deliver strong outcomes. Our global platform invests across Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. Across these focus areas, we bring deep sector expertise and broad capabilities. We have 24 offices on four continents, more than 1,850 employees, and approximately $225 billion in assets under management. To learn more, visit www.baincapital.com. Follow @BainCapital on LinkedIn and X.

 

Media Contacts

Communications Director, Asia

 Australia

 Stuart Carson

Categories: News

Tags: